Rubella - 19 Studies Found Completed : Rubella Susceptibility in Multiparous Women : Rubella Vaccine : 2006-11-17 Completed : Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination : Measles/Rubella : 2014-06-04 : Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain) Completed : Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination : Measles/Rubella : 2014-05-28 : Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain) Not yet recruiting : Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella : Rubella Measles : 2017-05-09 : Biological: Measles and Rubella vaccine Completed : Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella : Rubella Measles : 2014-07-16 : Biological: Double viral (MR) vaccine Measles and Rubella vaccine, as single arm Completed : Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age : Measles; Mumps; Rubella : 2014-07-03 : Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209 Not yet recruiting : Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age : Measles Rubella Biological: Measles-rubella (MR) vaccine at 6 and 9 months Completed : Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations : Measles Mumps Rubella : 2013-01-21 : Biological: MMR Vaccine Administration of MMR Vaccine by Bio-Manguinhos or MMR Vaccine by GlaxoSmithKlin Completed : Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older : Rubella Mumps Measles : 2014-02-06 : Biological: Priorix® 1 do Completed : Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age : Rubella Mumps Measles : 2012-06-14 : Biological: Priorix® Sing Next >>>